MedPath

Analysis of factors predicting outcome of peginterferon plus ribavirin combination therapy for chronic hepatitis C-comparison between NK cell activity and other possible predictors

Not Applicable
Recruiting
Conditions
Chronic hepatitis C
Registration Number
JPRN-UMIN000003866
Lead Sponsor
Osaka Prefectural General Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

liver cirrhosis autoimmune hepatitis primary biliary cirrhosis malignancy depression drug abuse pregnant or lactating woman

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath